| ONCO-INNOVATIONS LTD. |
| Kanada |
| Gesundheit |
| CA68237C1059 / A3EKSZ |
| W1H (Frankfurt) |
| FRA:W1H, ETR:W1H, W1H:GR |
| - |
| https://oncoinnovations.c.. |
|
Onco-Innovations Limited is a pre-clinical stage biotechnology company focused on the development of innovative drug candidates targeting cancer. The company’s primary mission is to advance next-generation therapies that address unmet clinical need..
>Volltext.. |
| 54.15 Mio. EUR |
| 53.83 Mio. EUR |
| 0.1 Mio. EUR |
| -7.18 Mio. EUR |
| -9.53 Mio. EUR |
| -0.2 EUR |
| - |
| 0.33 Mio. EUR |
| -3.52 Mio. EUR |
| 1.15 |
| - |
| - |
| - |
| - |
| - |
| - |
| ONCO-INNOVATIONS, ONCO INNOVATIONS |
| 20.06.26 |
|